dual IL-2/IL-15 inhibitor (Neoleukin Therapeutics)

N/A

Report date: 2025/03/19 11:37:32

Base Information

Drug Namedual IL-2/IL-15 inhibitor (Neoleukin Therapeutics)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionInterleukin-15 receptors antagonistsInterleukin-2 receptor antagonists
TargetsInterleukin-15 receptorsInterleukin-2 receptor
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeoleukin Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeoleukin Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A